OvaScience (OVAS) announced after the close Wednesday that it is reducing its workforce by approximately 30 percent and will slow the commercial expansion of its fertility treatment AUGMENT.
from RTT - Before the Bell http://ift.tt/2hZHOFm
via IFTTT
No comments:
Post a Comment